Page last updated: 2024-11-06

4-nitropyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Nitropyridine is a heterocyclic compound with a nitro group at the 4-position. It is a pale yellow solid that is used as an intermediate in the synthesis of other chemicals, such as pesticides and pharmaceuticals. 4-Nitropyridine is also used as a reagent in organic synthesis. It has been shown to be a potent inhibitor of the enzyme acetylcholinesterase, which is responsible for the breakdown of the neurotransmitter acetylcholine. This suggests that 4-nitropyridine may have potential as a therapeutic agent for the treatment of Alzheimer's disease. 4-Nitropyridine is also studied for its potential as a catalyst in various chemical reactions. It is an important compound in the field of organic chemistry and is being investigated for its potential applications in various fields, including medicine, agriculture, and materials science.'

Cross-References

ID SourceID
PubMed CID70734
CHEMBL ID4577515
SCHEMBL ID545380
MeSH IDM0149569

Synonyms (22)

Synonym
4-nitropyridine
1122-61-8
nsc30350
pyridine, 4-nitro-
nsc-30350
AKOS000267399
FT-0692561
4-nitro-pyridine
unii-59d3ds58zb
59d3ds58zb ,
nsc 30350
ai3-25255
SCHEMBL545380
FEXIEMAAKBNTFK-UHFFFAOYSA-N
DTXSID2074453
mfcd00054554
AS-35885
A925594
CHEMBL4577515
SB52565
SY029168
CS-0059175

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The mean elimination half-life of nifedipine prolonged significantly following diltiazem (2."( Dose dependent effect of diltiazem on the pharmacokinetics of nifedipine.
Fujimura, A; Hosoda, S; Kumagai, Y; Ohashi, K; Sakamoto, K; Sudo, T; Sugimoto, K; Tateishi, T; Toyo-oka, T; Toyosaki, N, 1989
)
0.28

Bioavailability

ExcerptReferenceRelevance
"05) and bioavailability (0."( Factors affecting the absolute bioavailability of nifedipine.
Clarke, H; George, CF; Martin, U; Rashid, TJ; Renwick, AG; Waller, DG, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1524436Substrate activity at recombinant Haemophilus influenzae Chloramphenicol nitroreductase expressed in Escherichia coli assessed as initial rate of reaction at 150 uM measured at 30 sec interval for 5 mins in presence of NADPH at pH 8 under 37 degC by UV-vi2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Investigating the promiscuity of the chloramphenicol nitroreductase from Haemophilus influenzae towards the reduction of 4-nitrobenzene derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.34 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index36.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (22.22%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]